Copyright © 2000 by the European Society of Cardiology.
Editorial
Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias
Cardiovascular Research and Training Institute, Aalst, Belgium
References
- Kulick DL, Hong R, Ryzen E. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of cardiac disease. Am Heart J. 1988;115:367373[CrossRef][ISI][Medline]
- DiCarlo LA, Morady F, Buitleir M, Krol RB, Schurig L, Annesley TM. Effects of magnesium sulphate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol. 1986;7:13561362[Abstract]
- Reinhart R, Marx J, Broste S, Haas R. Myocardial magnesium: relation to laboratory and clinical variables in patients undergoing cardiac surgery. J Am Coll Cardiol. 1991;17:651656[Abstract]
- Tzivoni A, Keren. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol. 1990;65:13971399[CrossRef][ISI][Medline]
- Frick M, Darpö B, Östergren J, Rosenqvist M. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation. Eur Heart J. 2000;21:11771185
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||